Recently, the Supreme Court in Apex Laboratories (P.) Ltd. finally settled the controversy regarding the allowance of expenditure incurred by pharmaceutical companies on the gifting of freebies to doctors under the IT Act. By holding that the practice is opposed to the MCI Regulations and consequently to public policy, this decision has created new challenges for the pharmaceutical and allied health sector companies.

Audio Source: An article published on the LKS website in May 2022 https://www.lakshmisri.com/insights/articles/apex-laboratories-a-bitter-pill-to-swallow-for-the-healthcare-sector/

Author: Tanmay Bhatnagar, Sr. Associate (LKS)

Voice: Anushka Verma, Associate (LKS)

www.lakshmisri.com